News

Two newly FDA‑cleared blood tests for Alzheimer’s disease are making diagnosis more accessible than ever. These simple plasma tests can help identify amyloid and tau pathology without the need for a lumbar puncture or PET scan.

Deadline extended! Apply for the 2026 Duke-UNC ADRC REC Scholar program by January 16, 2026. Early-career researchers in Alzheimer’s and related dementias receive funding, mentorship, and access to core resources

The Ruth K. Broad Foundation, a support corporation of Duke University, has several grant programs for basic research in the neurosciences at Duke.

The Alzheimer Diagnosis in older Adults with Chronic Conditions (ADACC) Network is soliciting proposals for pilot projects focused on blood-based biomarker testing for Alzheimer’s disease for older adults with multiple chronic conditions.

A new study published in Neuron, led by Juan Song, PhD, sheds light on how Alzheimer’s disease affects the brain. The findings could lead to new forms of therapy.

The Rebecca Clark Staff Award for Moral Courage winner is training the next generation of biomedical researchers.